Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

ECPA Welcomes EFSA's Scientific Input but sees it as Late and Fears ED Rules will Crush Innovation in Farm Inputs


News provided by

The European Crop Protection Association (ECPA)

20 Mar, 2013, 14:05 GMT

Share this article

Share toX

Share this article

Share toX

BRUSSELS, March 20, 2013 /PRNewswire/ --

Today the European Food Safety Authority's (EFSA) Scientific Committee published its opinion on identifying endocrine disrupting chemicals (EDs).  ECPA welcomed the EFSA opinion but is concerned how late the input has been requested in a process that has been rushed to meet political deadlines.  The process to create new EU rules to identify and regulate EDs, threatens to take action based on theoretical rather than proven risks, to the detriment of European industry competitiveness and the broader public good.

"ECPA appreciates EFSA'sscientific input but sees its contribution as unfortunately late when the ED criteria are all but finalised.  It is even more perplexing why the Commission's own scientific committees have been absent from the development of the ED criteria" - said Friedhelm Schmider, Director General of European Crop Protection Association (ECPA).  "Endocrine disruption is a complex scientific issue and the Commission's own scientific committees could have made an invaluable contribution in providing clear expert advice to European regulators and politicians".  

Ignoring established scientific principles and rushing the development of the ED criteria risks dealing a crushing blow to European industrial innovation.  The criteria as recently drafted would deny EU farmers access to essential and innovative plant protection products which they safely use today. This will deprive EU farmers of important tools at a time when productivity must rise to meet increasing demand for food.

ECPA is clear that protecting human and environmental safety should not be compromised. Satisfying this goal and retaining industry competiveness can co-exist if the ED criteria focus on actual rather than perceived risks. The EFSA opinion raises several important technical considerations which ECPA welcomed and which demand further consideration in this respect:

  • risk assessment - EDs can be treated like most other substances and risk assessment is a suitable method to evaluate the level of concern posed by EDs, i.e. consideration of actual or predicted exposure and not only hazard;
  • potency and severity - are important and relevant indicators of potential concern, and should be considered; and
  • establishing safe dose/concentrations, above which adverse effects occur, is possible.

Further input of EFSA's Scientific Committee on the many complex topics around endocrine disruption is essential.  As the scientific debate continues on these topics, robust and independent scientific advice is important to ensure European regulation addresses substantiated concerns rather than fear. A broader return to risk assessment over hazard assessment would meaningfully contribute towards this goal.

For the online version please follow the link: http://www.ecpa.eu/news-item/human-health/03-20-2013/716/ecpa-welcomes-efsa-s-scientific-input-sees-it-late-and-fears-e

Notes to editor

(1). ECPA (European Crop Protection Association) represents the European R&D based manufacturers of plant protection products (pesticides).  Plant protection products are essential tools to help EU farmers protect their crops from pests and diseases.

(2). Under the new pesticides regulation, Regulation 1107/2009, substances considered to have "endocrine disrupting properties" in humans or non-target species will not be approved.  The inclusion of this hazard based criteria is a departure from the established tool of risk assessment for evaluating the safety of substances, where both the hazard and exposure to a substance is considered.  No criteria are included to define what are considered to be endocrine disrupting properties, however, the European Commission must come forward with a proposal for these criteria for pesticides by 13 December 2013.  

(3). Within the Commission, the responsibility for preparing the scientific criteria has been delegated to DG Environment, who has been tasked with developing criteria for the identification of endocrine disruptors which will be applied to general chemicals (REACH), biocides (Regulation 528/2012) as well as to pesticides (Regulation 1107/2009), and possibly also to cosmetics (Regulation 1223/2009).

(4). In February 2013, DG Environment released a revised proposal for the criteria for the identification of endocrine disruptors, "Revised version of possible elements for criteria for identification of endocrine disrupters".  The final horizontal criteria are expected to be published in May 2013 after which they will be transposed into the different pieces of sectorial legislation, including Regulation 1107/2009 for pesticides.

(5). In September 2012, DG Sanco requested a scientific opinion from the EFSA Scientific Committee (European Food Safety Authority) as part of the input into the process for the development of the endocrine disruption criteria.

(6) The European Commission  has three non-food related Scientific Committees, these include: Scientific Committee on Consumer Safety (SCCS), Scientific Committee on Health and Environmental Risks (SCHER), Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR).  Although these committees have the relevant expertise none have been formally consulted during the process for the development of the criteria for the identification of endocrine disruptors.

(7) Experts from industry, including ECPA, have contributed significant scientific expertise to the issue of endocrine disruption.  Through ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals, industry experts developed a regulatory proposal for managing endocrine disruptors (Bars, R., I. Fegert, M. Gross, D. Lewis, L. Weltje, A. Weyers, J.R. Wheeler, Galay-Burgos, M.   2012.  Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.  Regul Toxicol Pharmacol.  64(1):143-154).  The publication was recently awarded the title of "Best Published Paper Advancing the Science of Risk Assessment" by the Society of Toxicology.

The European Crop Protection Association (ECPA) represents the crop protection industry interests at European level. Its members include all major companies and national associations across Europe.
Contact:

Peter Day , Senior Health & Technical Affairs Manager, peter.day@ecpa.eu
Anna Seretny, Communications Coordinator, anna.seretny@ecpa.eu
European Crop Protection Association, aisbl,
Switchboard : +32(0)2-663-1550

For more general information:

http://www.ecpa.eu - http://www.pesticideinformation.eu - facebook.com/cropprotection -  twitter.com/cropprotection

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.